Phase 4
N=44
Conditioned Pharmacotherapeutic Effects in Hypertension
Hypertension
Bottom Line
View on ClinicalTrials.gov: NCT02056626 ↗Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Mean Systolic Blood Pressure — 151.59; 152.64; 155.42; 151.74 mmHg
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- carvedilol (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Rochester
- Primary completion
- Nov 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Systolic Blood Pressure |
138.90; 136.38; 139.27; 134.94 | — |
| PRIMARY Mean Systolic Blood Pressure |
138.90; 136.38; 139.27; 134.94 | — |
| PRIMARY Mean Systolic Blood Pressure |
138.90; 136.38; 139.27; 134.94 | — |
Summary
The proposed research is designed to determine if the application of classical conditioning operations could influence the clinical effects of a regimen of antihypertensive drug therapy. It will be determined if, capitalizing on conditioned pharmacotherapeutic effects, patients can be effectively treated with smaller cumulative amounts of drug.
Eligibility Criteria
Inclusion Criteria
- systolic blood pressure between 140-160 mmHG
- between 18-80 years old
Exclusion Criteria
- abnormal renal function
- currently pregnant, or trying to become pregnant
- being treated with a beta-blocker
- use of illicit drugs
Data sourced from ClinicalTrials.gov (NCT02056626). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.